These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1452222)

  • 1. Structural basis of antigenic variation: studies of influenza virus neuraminidase.
    Colman PM
    Immunol Cell Biol; 1992 Jun; 70 ( Pt 3)():209-14. PubMed ID: 1452222
    [No Abstract]   [Full Text] [Related]  

  • 2. Antigenic variation and the structure of influenza virus glycoproteins.
    Laver WG
    Microbiol Sci; 1984 May; 1(2):37-43. PubMed ID: 6444094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular basis of antigenic variation in influenza virus.
    Air GM; Laver WG
    Adv Virus Res; 1986; 31():53-102. PubMed ID: 2428216
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibody recognition of the influenza virus neuraminidase.
    Air GM; Laver WG; Webster RG; Els MC; Luo M
    Cold Spring Harb Symp Quant Biol; 1989; 54 Pt 1():247-55. PubMed ID: 2484161
    [No Abstract]   [Full Text] [Related]  

  • 5. Three-dimensional structure of the neuraminidase of influenza virus A/Tokyo/3/67 at 2.2 A resolution.
    Varghese JN; Colman PM
    J Mol Biol; 1991 Sep; 221(2):473-86. PubMed ID: 1920428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antigenic specificity of the neuraminidases of epidemic strains of influenza A/H3N2 viruses circulating in the USSR 1983-1985].
    Liubovtseva OV; Iakhno MA; Zakstel'skaia LIa
    Vopr Virusol; 1987; 32(3):283-5. PubMed ID: 2445104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic analysis of recent H1N1 influenza viruses with monoclonal antibodies.
    Yamada A; Cao MS; Imanishi J; Oyama S; Abe A; Katagiri S
    Acta Virol; 1991 Aug; 35(4):343-9. PubMed ID: 1724874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refined atomic structures of N9 subtype influenza virus neuraminidase and escape mutants.
    Tulip WR; Varghese JN; Baker AT; van Donkelaar A; Laver WG; Webster RG; Colman PM
    J Mol Biol; 1991 Sep; 221(2):487-97. PubMed ID: 1920429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenicity of the N8 influenza A virus neuraminidase: existence of an epitope at the subunit interface of the neuraminidase.
    Saito T; Taylor G; Laver WG; Kawaoka Y; Webster RG
    J Virol; 1994 Mar; 68(3):1790-6. PubMed ID: 7509002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structures of two mutant neuraminidase-antibody complexes with amino acid substitutions in the interface.
    Tulip WR; Varghese JN; Webster RG; Laver WG; Colman PM
    J Mol Biol; 1992 Sep; 227(1):149-59. PubMed ID: 1522584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystals of antibodies complexed with influenza virus neuraminidase show isosteric binding of antibody to wild-type and variant antigens.
    Laver WG; Webster RG; Colman PM
    Virology; 1987 Jan; 156(1):181-4. PubMed ID: 3811232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contacts between influenza virus N9 neuraminidase and monoclonal antibody NC10.
    Lee JT; Air GM
    Virology; 2002 Sep; 300(2):255-68. PubMed ID: 12350356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reverse engineering the antigenic architecture of the haemagglutinin from influenza H5N1 clade 1 and 2.2 viruses with fine epitope mapping using monoclonal antibodies.
    Rockman S; Camuglia S; Vandenberg K; Ong C; Baker MA; Nation RL; Li J; Velkov T
    Mol Immunol; 2013 Apr; 53(4):435-42. PubMed ID: 23127859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences.
    Gravel C; Li C; Wang J; Hashem AM; Jaentschke B; Xu KW; Lorbetskie B; Gingras G; Aubin Y; Van Domselaar G; Girard M; He R; Li X
    Vaccine; 2010 Aug; 28(36):5774-84. PubMed ID: 20621113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza.
    Job ER; Schotsaert M; Ibañez LI; Smet A; Ysenbaert T; Roose K; Dai M; de Haan CAM; Kleanthous H; Vogel TU; Saelens X
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29167342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parainfluenza virus type 2 haemagglutinin-neuraminidase glycoprotein characterized with monoclonal antibodies.
    Rydbeck R; Löve A; Orvell C
    J Gen Virol; 1988 Apr; 69 ( Pt 4)():931-5. PubMed ID: 2451708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuraminidase-inhibition assay for the identification of influenza A virus neuraminidase virus subtype or neuraminidase antibody specificity.
    Pedersen JC
    Methods Mol Biol; 2014; 1161():27-36. PubMed ID: 24899417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection and analysis of antigenic variants of the neuraminidase of N2 influenza viruses with monoclonal antibodies.
    Webster RG; Hinshaw VS; Laver WG
    Virology; 1982 Feb; 117(1):93-104. PubMed ID: 7064355
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection.
    Mozdzanowska K; Maiese K; Furchner M; Gerhard W
    Virology; 1999 Feb; 254(1):138-46. PubMed ID: 9927581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuraminidase antigenic erythrocytic diagnostic agent in determining antibodies to the neuraminidase of influenza A viruses].
    Tamendarova NCh; Shuratov IKh; Karal'nik BV; Ansarieva KG; Nietkalieva SA
    Vopr Virusol; 1985; 30(3):369-73. PubMed ID: 2413631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.